Ascendis Pharma A (ASND) Cash from Investing Activities Growth (5y) (2019 - 2026)
Ascendis Pharma A (ASND) Cash from Investing Activities Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ascendis Pharma A | 15.35 Bn | 14.68 Bn | 268.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.29% |
| Dec 31, 2025 | 45.85% |
| Sep 30, 2025 | -14.89% |
| Jun 30, 2025 | 54.88% |
| Mar 31, 2025 | 35.80% |
| Dec 31, 2024 | 20.65% |
| Sep 30, 2024 | 16.86% |
| Jun 30, 2024 | 31.11% |
| Mar 31, 2024 | 36.68% |
| Dec 31, 2023 | 51.23% |
| Sep 30, 2023 | 82.21% |
| Jun 30, 2023 | 164.68% |
| Mar 31, 2023 | 348.08% |
| Dec 31, 2022 | -24.06% |
| Sep 30, 2022 | 152.18% |
| Jun 30, 2022 | 117.02% |
| Mar 31, 2022 | 155.88% |
| Dec 31, 2021 | -310.28% |
| Sep 30, 2021 | 167.47% |
| Jun 30, 2021 | 114.34% |